< Back to previous page
Researcher
Robin BRUYNDONCKX
- Research Expertise (University of Antwerp):statistical analyses on data concerning antibiotic use and resistance
- Keywords (University of Antwerp):ANTIBIOTICS, STATISTICS, Medicine
- Keywords (Hasselt University):Mathematics
- Disciplines (University of Antwerp):Biostatistics
- Disciplines (Hasselt University):Biostatistics
- Research techniques (University of Antwerp):statistics
- Users of research expertise (University of Antwerp):laboratory of medical microbiology
Affiliations
- Data Science Institute (Research institute)
Member
From1 Jun 2019 → 30 Jun 2024 - Primary and interdisciplinary care Antwerp (ELIZA) (Research group)
Member
From1 Jan 2019 → Today - Laboratory of Medical Microbiology (LMM) (Research group)
Member
From1 Jan 2019 → 13 May 2022 - Vaccine & Infectious Disease Institute (VAXINFECTIO) (Research group)
Member
From1 Oct 2016 → 31 Dec 2018 - Mathematics and statistics (Department)
Member
From1 Jan 2013 → 30 Jun 2024 - Faculty of Sciences (Faculty)
Member
From1 Oct 2012 → 30 Jun 2024 - Centre for Statistics (Research group)
Member
From1 Oct 2012 → 30 Jun 2024 - Research Institute Center for Statistics (Research institute)
Member
From1 Oct 2012 → 31 May 2019 - Applied Mathematics (Department)
Member
From1 Oct 2012 → 31 Dec 2012
Projects
1 - 2 of 2
- Preparatory support for the statistical evaluation of the compliance analysis of GM plant field trialsFrom13 Nov 2018 → 12 Nov 2020Funding: Other European institutions (outside EU)
- Identification of determinants of antibiotic use and improvement of prescribing behavior using innovative statistical approachesFrom1 Oct 2018 → 30 Jun 2021Funding: FWO fellowships
Publications
1 - 10 of 53
See also Robin Bruyndonckx for publications of University of Antwerp.
Here below the publications of Hasselt University.
- Antibiotic or gastric acid inhibitor use during pregnancy and postpartum depression: Population-based cohort study(2024)Published in: Acta Obstetricia Et Gynecologica ScandinavicaISSN: 0001-6349Issue: 8Volume: 103Pages: 1596 - 1605
- Validation of a rapid SARS-CoV-2 antibody test in general practice(2023)Published in: Bmj OpenISSN: 2044-6055Issue: 5Volume: 13
- Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC(4)E trial in 15 European countries(2023)Published in: The European journal of health economicsISSN: 1618-7598Issue: 6Volume: 24Pages: 909 - 922
- Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study(2023)Published in: Drug SafetyISSN: 0114-5916Issue: 5Volume: 46Pages: 467 - 478
- Using microbiological data to improve the use of antibiotics for respiratory tract infections: A protocol for an individual patient data meta-analysis(2023)Published in: Plos OneISSN: 1932-6203Issue: 11Volume: 18
- Nationwide implementation of online communication skills training to reduce overprescribing of antibiotics: a stepped-wedge cluster randomized trial in general practice(2022)Published in: Jac-antimicrobial ResistanceISSN: 2632-1823Issue: 3Volume: 4
- Antibiotic use during pregnancy and the risk of preterm birth: a population-based Swedish cohort study(2022)Published in: The journal of antimicrobial chemotherapyISSN: 0305-7453Issue: 5Volume: 77Pages: 1461 - 1467
- Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up(2022)Published in: Bmj OpenISSN: 2044-6055Issue: 9Volume: 12
- Impact of Adding Oseltamivir to Usual Care on Quality-Adjusted Life-Years During Influenza-Like Illness(2022)Published in: Value in healthISSN: 1098-3015Issue: 2Volume: 25Pages: 178 - 184
- Belgian population norms for the EQ-5D-5L, 2018(2022)Published in: Quality of Life ResearchISSN: 0962-9343Issue: 2Volume: 31Pages: 527 - 537